Tamoxifen inhibits macrophage FABP4 expression through the combined effects of the GR and PPARγ pathways. (Q50874092)

24 March 2018

title

Tamoxifen inhibits macrophage FABP4 expression through the combined effects of the GR and PPARγ pathways. (English)

1 reference

24 March 2018

1 reference

Meixiu Jiang

1

1 reference

24 March 2018

Ling Zhang

2

1 reference

24 March 2018

Xingzhe Ma

3

1 reference

24 March 2018

Wenquan Hu

4

1 reference

24 March 2018

Yuanli Chen

5

1 reference

24 March 2018

Miao Yu

6

1 reference

24 March 2018

Qixue Wang

7

1 reference

24 March 2018

Xiaoju Li

8

1 reference

24 March 2018

Zhinan Yin

9

1 reference

24 March 2018

Yan Zhu

10

1 reference

24 March 2018

Xiumei Gao

11

1 reference

24 March 2018

David P Hajjar

12

1 reference

24 March 2018

Yajun Duan

13

1 reference

24 March 2018

Jihong Han

14

1 reference

24 March 2018

language of work or name

English

0 references

publication date

1 September 2013

1 reference

24 March 2018

published in

Biochemical Journal

1 reference

24 March 2018

volume

454

1 reference

24 March 2018

page(s)

467-477

1 reference

24 March 2018

issue

3

1 reference

24 March 2018

Fatty acid-binding proteins--insights from genetic manipulations

cites work

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Improved glucose and lipid metabolism in genetically obese mice lacking aP2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Peroxisome proliferator activated receptor gamma, CCAAT/enhancer-binding protein alpha, and cell cycle status regulate the commitment to adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Statins synergize dexamethasone-induced adipocyte fatty acid binding protein expression in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Atorvastatin reduces CD68, FABP4, and HBP expression in oxLDL-treated human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

The adipocyte lipid binding protein (ALBP/aP2) gene facilitates foam cell formation in human THP-1 macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Adipocyte fatty acid binding protein in atherosclerotic plaques is associated with local vulnerability and is predictive for the occurrence of adverse cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Molecular therapy of breast cancer: progress and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Study of the mechanisms involved in the vasorelaxation induced by (-)-epigallocatechin-3-gallate in rat aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Tamoxifen improves endothelial function and reduces carotid intima-media thickness in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Influence of tamoxifen on carotid intima-media thickness in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Tamoxifen effects on endothelial function and cardiovascular risk factors in men with advanced atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Regulation of lipid droplet cholesterol efflux from macrophage foam cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Functional interplay between the macrophage scavenger receptor class B type I and pitavastatin (NK-104).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Deficiency of PXR decreases atherosclerosis in apoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Adipogenic differentiating agents regulate expression of fatty acid binding protein and CD36 in the J744 macrophage cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Activation of liver X receptor induces macrophage interleukin-5 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

PPARgamma activation induces the expression of the adipocyte fatty acid binding protein gene in human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Estrogen signaling and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

A woman's heart: the impact of adjuvant endocrine therapy on cardiovascular health

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Clinical review: Effect of endocrine therapies on bone in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Synergistic upregulation of low-density lipoprotein receptor activity by tamoxifen and lovastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Long term effects of tamoxifen on blood lipid values in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Induction of macrophage scavenger receptor type BI expression by tamoxifen and 4-hydroxytamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Expression of the differentiation-induced gene for fatty acid-binding protein is activated by glucocorticoid and cAMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Circulating Adipocyte Fatty Acid-Binding Protein Levels and Cardiovascular Morbidity and Mortality in Patients With Coronary Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

21 January 2018

Identifiers

DOI

10.1042/BJ20130580

1 reference

24 March 2018

PubMed ID

23805908

1 reference

24 March 2018